Wolfgang Brückl

Research output

Research output per year 1993 2001 2003 2005 2017 2023 2024

• 60 Original Article (Journal)
• 9 Case report
• 8 Review article
• 5 Editorial
• 4 More
  • 4 published Abstract (Journal)

Research output per year

Research output per year

Search results

• 2024

  Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315): a randomised, international, multicentre, double-blind, placebo-controlled trial

  Griesinger, F., Sebastian, M., Brueckl, W. M. (Co-author), Hummel, H.-D., Jaeschke, B., Kern, J., Wesseler, C., Jänicke, M., Fleitz, A., Zacharias, S., Hipper, A., Groth, A., Weichert, W., Dörfel, S., Petersen, V., Schröder, J., Wilke, J., Eberhardt, W. E. E., Thomas, M. & CRISP Registry Group, 2 Mar 2024, In: JTO Clinical and Research Reports. 5, 4, p. 850-859 10 p.

  Research output: Contribution to journal › Original Article (Journal) › peer-review

  Open Access

  • Monotherapy 100%
  • Placebo 100%
  • Non-Small Cell Lung Cancer 100%
  • Abatacept 100%
  • Magnetic Resonance Imaging 66%
  12 Citations (Web of Science)

• Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma

  Feng, Z., Yuan, L., Ma, L., Yu, W., Kheir, F., Kaesmann, L., Brueckl, W. M. (Co-author), Jin, K., Wang, D., Shen, Y., Li, R. & Tian, H., 30 Jun 2024, In: TRANSLATIONAL LUNG CANCER RESEARCH. 13, 6, 20 p.

  Research output: Contribution to journal › Original Article (Journal) › peer-review

  Open Access

  • Mitophagy 100%
  • Prolyl Isomerase 100%
  • Cell Infiltration 20%
  • Immunocompetent Cell 20%
  • Survival Rate 13%
• 2023

  Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach.

  Englmeier, F., Bleckmann, A., Brückl, W. (Co-author), Griesinger, F., Fleitz, A. & Nagels, K., 2023, In: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY . 149, 4, p. 1495-1511

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  12 Citations (Web of Science)

• Combination of the platelet-to-lymphocyte ratio and fibrinogen may predict 5-year overall survival of patient in non-small cell lung cancer treated with surgery

  Luo, Y., Lin, K., Zhang, M., Goto, T., Brueckl, W. (Co-author), Lin, J., Liu, X., Weng, J. & Ye, Y., 2023, In: Journal of Thoracic Disease.

  Research output: Contribution to journal › Original Article (Journal) › peer-review

  • Adenosquamous Carcinoma 100%
  1 Citation (Web of Science)

• Comparative efficacy and safety of multitarget angiogenesis inhibitor combined with immune checkpoint inhibitor and nivolumab monotherapy as second-line or beyond for advanced lung adenocarcinoma in driver-negative patients: a retrospective comparative cohort study

  Yu, L., Xu, J., Qiao, R., Zhong, H., Brueckl, W. (Co-author) & Zhong, R., 2023, In: TRANSLATIONAL LUNG CANCER RESEARCH.

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  3 Citations (Web of Science)

• Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study.

  Brueckl, W. M. (First author), Reck, M., Schäfer, H., Neben, K., Griesinger, F., Rawluk, J., Krüger, S., Kokowski, K., Ficker, J. H. (Co-author), Möller, M., Schueler, A. & Laack, E., 2023, In: JOURNAL OF GERIATRIC ONCOLOGY. 14, 1, p. 101394

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  2 Citations (Web of Science)
• 2022

  A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer

  Zhang, Z., Xie, S., Cai, W., Yang, C., Hong, Z., Lin, Y., Zhu, J., Lin, Z., Christoph, D., Bohnenberger, H., Kepka, L., Brueckl, W. (Co-author), Van Houtte, P., Kang, M. & Lin, J., 2022, In: TRANSLATIONAL LUNG CANCER RESEARCH. 11, 1, p. 75-+

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  6 Citations (Web of Science)

• Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP)

  Faehling, M., Witte, H., Sebastian, M., Ulmer, M., Satzler, R., Steinestel, K., Bruckl, W. (Co-author), Evers, G., zum Buschenfelde, C. & Bleckmann, A., 2022, In: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 14, p. 17588359221085333

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  7 Citations (Web of Science)

• The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.

  Christopoulos, P., Kluck, K., Kirchner, M., Lüders, H., Roeper, J., Falkenstern-Ge, R.-F., Szewczyk, M., Sticht, F., Saalfeld, F. C., Wesseler, C., Hackanson, B., Dintner, S., Faehling, M., Kuon, J., Janning, M., Kauffmann-Guerrero, D., Kazdal, D., Kurz, S., Eichhorn, F. & Bozorgmehr, F. & 17 others, Shah, R., Tufman, A., Wermke, M., Loges, S., Brueckl, W. M. (Co-author), Schulz, C., Misch, D., Frost, N., Kollmeier, J., Reck, M., Griesinger, F., Grohé, C., Hong, J.-L., Lin, H. M., Budczies, J., Stenzinger, A. & Thomas, M., 2022, In: EUROPEAN JOURNAL OF CANCER . 170, p. 106-118

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  17 Citations (Web of Science)
• 2021

  Afatinib as first-line treatment in patients with

  Brückl, W. (First author), Reck, M., Griesinger, F., Schäfer, H., Kortsik, C., Gaska, T., Rawluk, J., Krüger, S., Kokowski, K., Budweiser, S., Ficker, J. H. (Co-author), Hoffmann, C., Schüler, A. & Laack, E., 2021, In: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 13, p. 17588359211012361

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  10 Citations (Web of Science)

• Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV

  Brueckl, W. M. (First author), Reck, M., Rittmeyer, A., Kollmeier, J., Wesseler, C., Wiest, G. H., Christopoulos, P., Stenzinger, A., Tufman, A., Hoffknecht, P., Ulm, B., Reich, F. (Co-author), Ficker, J. H. (Co-author) & Laack, E., 2021, In: TRANSLATIONAL LUNG CANCER RESEARCH. 10, 7, p. 309-3105

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  28 Citations (Web of Science)

• Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)

  Brueckl, N. F., Wirtz, R. M., Reich, F. P. M., Veltrup, E., Zeitler, G., Meyer, C. (Co-author), Wuerflein, D., Ficker, J. H. (Co-author), Eidt, S. & Brueckl, W. M. (Last author), 2021, In: TRANSLATIONAL LUNG CANCER RESEARCH. 10, 11, p. 4106-+

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  5 Citations (Web of Science)
• 2020

  C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.

  Riedl, J. M., Barth, D. A., Brueckl, W. M., Zeitler, G., Foris, V., Mollnar, S., Stotz, M., Rossmann, C. H., Terbuch, A., Balic, M., Niedrist, T., Bertsch, T. (Co-author), Stoeger, H., Pichler, M., Olschewski, H., Absenger, G., Ficker, J. H. (Co-author), Gerger, A. & Posch, F., 2020, In: Cancers. 12, 8

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  58 Citations (Web of Science)

• Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.

  Brueckl, W. M. (First author), Reck, M., Rittmeyer, A., Kollmeier, J., Wesseler, C., Wiest, G. H., Christopoulos, P., Tufman, A., Hoffknecht, P., Ulm, B., Reich, F. (Co-author), Ficker, J. H. (Co-author) & Laack, E., 2020, In: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 14, p. 1179554920951358

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  24 Citations (Web of Science)
• 2019

  [Refractory Dyspnea in Advanced COPD: Palliative Treatment with Opioids].

  Ficker, J. H. (First author) & Brückl, W. (Last author), 2019, In: PNEUMOLOGIE. 73, 7, p. 430-438

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  2 Citations (Web of Science)

• Metastatic lung cancer-treatable molecular alterations

  Br?ckl, W. (First author) & Ficker, J. H. (Last author), 2019, In: PNEUMOLOGE. 16, 6, p. 343-352

  Research output: Contribution to journal › Original Article (Journal) › peer-review
• 2018

  [Rebiopsy for Patients with Lung Cancer - Joint Opinion from both the Endoscopic and Thoracic Oncology Sections of the German Society of Pneumology (DGP)].

  Brückl, W. (First author), Ficker, J. H. (Co-author), Tiemann, M., Schumann, C., Reinmuth, N., Heigener, D., Schütte, W., Eberhardt, R., Darwiche, K. & Wagner, M. (Last author), 2018, In: PNEUMOLOGIE. 72, 9, p. 617-623

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  1 Citation (Web of Science)

• Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice - results from the ElderTac study.

  Brueckl, W. M. (First author), Achenbach, H. J., Ficker, J. H. (Co-author) & Schuette, W., 2018, In: BMC CANCER. 18, 1, p. 333

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  8 Citations (Web of Science)
• 2017

  [Haemoptysis : Intensive care management of pulmonary hemorrhage].

  Ficker, J. H. (First author), Brückl, W. (Co-author), Suc, J. & Geise, A. T. (Last author), 2017, In: INTERNIST . 58, 3, p. 218-225

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  3 Citations (Web of Science)

• [Liquid Biopsy: Detection of Molecular Markers for Treatment Decisions in Lung Cancer].

  Brückl, W. (First author), Wirtz, R. M., Bertsch, T. (Co-author), Ficker, J. H. (Co-author) & Jung, A., 2017, In: PNEUMOLOGIE. 71, 3, p. 151-163

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  5 Citations (Web of Science)

• Advanced non-small cell lung cancer (NSCLC) with activating EGFR mutations: first-line treatment with afatinib and other EGFR TKIs.

  Brückl, W. (First author), Tufman, A. & Huber, R. M., 2017, In: EXPERT REVIEW OF ANTICANCER THERAPY. 17, 2, p. 143-155

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  25 Citations (Web of Science)

• Comparison of

  Erber, R., Stöhr, R., Herlein, S., Giedl, C., Rieker, R. J., Fuchs, F., Ficker, J. H. (Co-author), Hartmann, A., Veltrup, E., Wirtz, R. M. & Brueckl, W. M. (Last author), 2017, In: ANTICANCER RESEARCH . 37, 12, p. 6771-6778

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  25 Citations (Web of Science)
• 2015

  [Estrogen Receptors and their Impact for Prognosis and Therapy of Lung Cancer - New Insights to an Underestimated Mechanism].

  Brückl, W. (First author), Al-Batran, S. E., Ficker, J. H. (Co-author), Wirtz, R. M. & Atmaca, A., 2015, In: PNEUMOLOGIE. 69, 6, p. 35-60

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  2 Citations (Web of Science)

• SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer.

  Atmaca, A., Wirtz, R. W., Werner, D., Steinmetz, K., Claas, S., Brueckl, W. M. (Co-author), Jäger, E. & Al-Batran, S.-E., 2015, In: BMC CANCER. 15, p. 300

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  22 Citations (Web of Science)
• 2014

  The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.

  Atmaca, A., Al-Batran, S.-E., Wirtz, R. M., Werner, D., Zirlik, S., Wiest, G., Eschbach, C., Claas, S., Hartmann, A., Ficker, J. H. (Co-author), Jäger, E. & Brueckl, W. M. (Last author), 2014, In: INTERNATIONAL JOURNAL OF CANCER. 134, 10, p. 2314-2321

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  25 Citations (Web of Science)
• 2013

  EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice.

  Gahr, S. (First author), Stoehr, R., Geissinger, E., Ficker, J. H. (Co-author), Brueckl, W. M. (Co-author), Gschwendtner, A., Gattenloehner, S., Fuchs, F. S., Schulz, C., Rieker, R. J., Hartmann, A., Ruemmele, P. & Dietmaier, W., 2013, In: BRITISH JOURNAL OF CANCER . 109, 7, p. 1821-1828

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  106 Citations (Web of Science)

• Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer.

  Brueckl, W. M. (First author), Al-Batran, S.-E., Ficker, J. H. (Co-author), Claas, S., Atmaca, A., Hartmann, A., Rieker, R. J. & Wirtz, R. M., 2013, In: INTERNATIONAL JOURNAL OF CANCER. 133, 8, p. 1825-1831

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  21 Citations (Web of Science)
• 2009

  Cdc2 as prognostic marker in stage UICC II colon carcinomas.

  Meyer, A., Merkel, S., Brückl, W. (Co-author), Schellerer, V., Schildberg, C., Campean, V., Hohenberger, W. & Croner, R. S., 2009, In: EUROPEAN JOURNAL OF CANCER . 45, 8, p. 1466-1473

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  20 Citations (Web of Science)

• Comparability of Microarray Data between Amplified and Non Amplified RNA in Colorectal Carcinoma

  Croner, R. S., Lausen, B., Schellerer, V., Zeittraeger, I., Wein, A., Schildberg, C., Papadopoulos, T. (Co-author), Dimmler, A., Hahn, E. G., Hohenberger, W. & Brueckl, W. M. (Last author), 2009, In: JOURNAL OF BIOMEDICINE & BIOTECHNOLOGY. 2009, p. 837170

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  9 Citations (Web of Science)

• Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.

  Gentner, B., Wein, A., Croner, R. S., Zeittraeger, I., Wirtz, R. M., Roedel, F., Dimmler, A., Dorlaque, L., Hohenberger, W., Hahn, E. G. & Brueckl, W. M. (Last author), 2009, In: ANTICANCER RESEARCH . 29, 1, p. 6-74

  Research output: Contribution to journal › Original Article (Journal) › peer-review

  28 Citations (Web of Science)
• 2008

  Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy.

  Naschberger, E., Croner, R. S., Merkel, S., Dimmler, A., Tripal, P., Amann, K. U., Kremmer, E., Brueckl, W. M. (Co-author), Papadopoulos, T. (Co-author), Hohenadl, C., Hohenberger, W. & Stürzl, M., 2008, In: INTERNATIONAL JOURNAL OF CANCER. 123, 9, p. 2120-2129

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  73 Citations (Web of Science)

• Molecular signature for lymphatic metastasis in colorectal carcinomas.

  Croner, R. S., Förtsch, T., Brückl, W. (Co-author), Rödel, F., Rödel, C., Papadopoulos, T. (Co-author), Brabletz, T., Kirchner, T., Sachs, M., Behrens, J., Klein-Hitpass, L., Stürzl, M., Hohenberger, W. & Lausen, B., 2008, In: ANNALS OF SURGERY . 247, 5, p. 803-810

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  29 Citations (Web of Science)
• 2007

  [Pronounced face swelling. What cause do you suspect?].

  Wiest, G. H. & Brückl, W., 2007, In: MMW. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT. 149, 16, p. 5

  Research output: Contribution to journal › Original Article (Journal) › peer-review

• Predictive and prognostic factors in small cell lung carcinoma (SCLC)--analysis from routine clinical practice.

  Brueckl, W. M. (First author), Herbst, L., Lechler, A., Fuchs, F., Schoeberl, A., Zirlik, S., Klein, P., Brunner, T. B., Papadopoulos, T. (Co-author), Hohenberger, W., Hahn, E. G. & Wiest, G. H., 2007, In: ANTICANCER RESEARCH . 26, 6C, p. 4825-4832

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  17 Citations (Web of Science)

• TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study

  Bacman, D., Merkel, S., Croner, R., Papadopoulos, T. (Co-author), Brueckl, W. (Co-author) & Dimmler, A., 2007, In: BMC CANCER. 7, p. 156

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  93 Citations (Web of Science)
• 2006

  Maintenance chemotherapy after chemoradiation improves survival of patients with locally advanced pancreatic carcinoma: a retrospective analysis of prospectively recruited patients.

  Brunner, T. B., Tinkl, D., Grabenbauer, G. G., Meyer, T., Brueckl, W. M. (Co-author) & Sauer, R., 2006, In: STRAHLENTHERAPIE UND ONKOLOGIE . 182, 4, p. 210-215

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  10 Citations (Web of Science)

• Non-compliance in surveillance for patients with previous resection of large (≥ 1cm) colorectal adenomas

  Brueckl, W. M. (First author), Fritsche, B., Seifert, B., Boxberger, F., Albrecht, H., Croner, R. S., Wein, A. & Hahn, E. G., 7 Dec 2006, In: WORLD JOURNAL OF GASTROENTEROLOGY. 12, 45, p. 7313-7318 6 p.

  Research output: Contribution to journal › Original Article (Journal) › peer-review

  • Colorectal Adenoma 100%
  • Surgery 100%
  • Diseases 25%
  • Symptom 25%
  • Awareness 25%
  15 Citations (Web of Science)
• 2005

  Age and manifestation related symptoms in familial adenomatous polyposis.

  Croner, R. S., Brueckl, W. M. (Co-author), Reingruber, B., Hohenberger, W. & Guenther, K., 2005, In: BMC CANCER. 5, p. 24

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  35 Citations (Web of Science)

• Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumours displaying either microsatellite stability (MSS) or instability (MSI).

  Brueckl, W. M. (First author), Grombach, J., Wein, A., Ruckert, S., Porzner, M., Dietmaier, W., Rümmele, P., Croner, R. S., Boxberger, F., Kirchner, T., Hohenberger, W., Hahn, E. G. & Jung, A., 2005, In: CANCER LETTERS . 223, 1, p. 137-142

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  18 Citations (Web of Science)

• Common denominator genes that distinguish colorectal carcinoma from normal mucosa.

  Croner, R. S., Foertsch, T., Brueckl, W. M. (Co-author), Guenther, K., Siebenhaar, R., Stremmel, C., Matzel, K. E., Papadopoulos, T. (Co-author), Kirchner, T., Behrens, J., Klein-Hitpass, L., Stuerzl, M., Hohenberger, W. & Reingruber, B., 2005, In: INTERNATIONAL JOURNAL OF COLORECTAL DISEASE . 20, 4, p. 353-362

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  26 Citations (Web of Science)

• Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma.

  Brueckl, W. M. (First author), Ballhausen, W. G., Förtsch, T., Günther, K., Fiedler, W., Gentner, B., Croner, R., Boxberger, F., Kirchner, T., Hahn, E. G., Hohenberger, W. & Wein, A., 2005, In: DISEASES OF THE COLON & RECTUM . 48, 6, p. 1275-1281

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  23 Citations (Web of Science)

• Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma.

  Croner, R. S., Peters, A., Brueckl, W. M. (Co-author), Matzel, K. E., Klein-Hitpass, L., Brabletz, T., Papadopoulos, T. (Co-author), Hohenberger, W., Reingruber, B. & Lausen, B., 2005, In: CANCER. 104, 2, p. 395-404

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  37 Citations (Web of Science)
• 2004

  Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).

  Link, K., Happich, K., Schirner, I., Jüngert, B., Brückl, V., Männlein, G., Brückl, W., Merkel, S., Göhl, J., Hohenberger, W., Hahn, E. G. & Wein, A., 2004, In: ANTICANCER RESEARCH . 24, 1, p. 385-391

  Research output: Contribution to journal › Original Article (Journal) › peer-review

  6 Citations (Web of Science)

• Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine.

  Brueckl, W. M. (First author), Heinze, E., Milsmann, C., Wein, A., Koebnick, C., Jung, A., Croner, R. S., Brabletz, T., Günther, K., Kirchner, T., Hahn, E. G., Hohenberger, W., Becker, H. & Reingruber, B., 2004, In: CANCER LETTERS . 203, 2, p. 181-190

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  34 Citations (Web of Science)

• Tissue preparation for gene expression profiling of colorectal carcinoma: three alternatives to laser microdissection with preamplification.

  Croner, R. S., Guenther, K., Foertsch, T., Siebenhaar, R., Brueckl, W. M. (Co-author), Stremmel, C., Hlubek, F., Hohenberger, W. & Reingruber, B., 2004, In: JOURNAL OF LABORATORY AND CLINICAL MEDICINE. 143, 6, p. 344-351

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  19 Citations (Web of Science)

• Transforming growth factor beta 1 dependent regulation of Tenascin-C in radiation impaired wound healing.

  Wehrhan, F., Rödel, F., Grabenbauer, G. G., Amann, K., Brückl, W. & Schultze-Mosgau, S., 2004, In: RADIOTHERAPY AND ONCOLOGY. 72, 3, p. 297-303

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  31 Citations (Web of Science)
• 2003

  Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer.

  Wein, A., Riedel, C., Brückl, W. (Co-author), Merkel, S., Ott, R., Hanke, B., Baum, U., Fuchs, F., Günther, K., Reck, T., Papadopoulos, T. (Co-author), Hahn, E. G. & Hohenberger, W., 2003, In: ONCOLOGY . 64, 2, p. 131-138

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  69 Citations (Web of Science)

• Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy.

  Brueckl, W. M. (First author), Moesch, C., Brabletz, T., Koebnick, C., Riedel, C., Jung, A., Merkel, S., Schaber, S., Boxberger, F., Kirchner, T., Hohenberger, W., Hahn, E. G. & Wein, A., 2003, In: ANTICANCER RESEARCH . 23, 2C, p. 1773-1777

  Research output: Contribution to journal › Original Article (Journal) › peer-review

  47 Citations (Web of Science)

• Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.

  Stickel, F., Jüngert, B., Brueckl, V., Schirner, I., Brueckl, W. M., Männlein, G., Hegewald, J., Mühldorfer, S., Bittorf, B., Hohenberger, W., Hahn, E. G. & Wein, A., 2003, In: ANTI-CANCER DRUGS. 14, 9, p. 745-749

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  14 Citations (Web of Science)
• 2002

  Initiation of CPAP therapy for OSA: does prophylactic humidification during CPAP pressure titration improve initial patient acceptance and comfort?

  Wiest, G. H., Harsch, I. A., Fuchs, F. S., Kitzbichler, S., Bogner, K., Brueckl, W. M. (Co-author), Hahn, E. G. & Ficker, J. H. (Last author), 2002, In: RESPIRATION . 69, 5, p. 406-412

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  29 Citations (Web of Science)